AYVAKIT (avapritinib) for the Treatment of Gastrointestinal Stromal Tumour (GIST)
Avapritinib is indicated for the treatment of unresectable or metastatic gastrointestinal stromal tumour (GIST). Credit: Blueprint Medicines Corporation.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more